drugset / Trial / NCT00748072

1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy

NCT00748072

Phase 4 Completed 162 enrolled University of Bari
RandomizedParallel-groupTriple-blindPrevention

Summary

The investigators evaluated the effect of pre-biopsy treatment with 1-deamino-8-D-arginine (DDAVP) on the incidence of post-biopsy bleeding complications. This is a IV phase single centre, double blind, randomized controlled study in patients, with acute and chronic nephropathy, undergoing ultrasound-guided percutaneous renal biopsy.

Timeline

Start
2008-08
Primary completion
2009-08
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 0.3 ug/kg Subcutaneous

Indications